Intralesional Hyaluronic Acid and Verapamil Injection in Peyronie's Disease

Summary

The aim of the present study is to investigate whether intralesional injections of Hyaluronic acid in the acute phase could reduce the progression of Peyronie's disease thanks to its interference with inflammatory and pro-fibrotic processes. Therefore, a prospective, longitudinal, double-blinded, randomized clinical study, has been designed to evaluate and compare the efficacy and safety of intralesional HA as compared with the use of verapamil injection in patients affected by Peyronie's disease.

Timeline

Start

2023-05-20

Primary completion

2024-05-20

Completion

2024-05-20

Drugs

Indications